(Q78031849)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11985528%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

title

Predictors of HIV-specific lymphocyte proliferative immune responses induced by therapeutic vaccination (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11985528%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

author name string

R B Moss

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11985528%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

M R Wallace

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11985528%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

R T Steigbigel

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11985528%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

S A Morrison

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11985528%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

W K Giermakowska

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11985528%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

C J Nardo

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11985528%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

J P Diveley

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11985528%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

D J Carlo

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11985528%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

publication date

1 May 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11985528%20AND%20SRC:MED&resulttype=core&format=json

Clinical and Experimental Immunology

10 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11985528%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

volume

128

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11985528%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11985528%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

page(s)

359-364

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11985528%20AND%20SRC:MED&resulttype=core&format=json

T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: a longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART).

10 December 2019

cites work

1 reference

12 December 2020

Two double-blinded, randomized, comparative trials of 4 human immunodeficiency virus type 1 (HIV-1) envelope vaccines in HIV-1-infected individuals across a spectrum of disease severity: AIDS Clinical Trials Groups 209 and 214.

1 reference

12 December 2020

Immune control of HIV-1 after early treatment of acute infection

1 reference

12 December 2020

Evaluation of HIV-1 Immunogen, an Immunologic Modifier, Administered to Patients Infected With HIV Having 300 to 549 × 10 6 /L CD4 Cell Counts A Randomized Controlled Trial

1 reference

12 December 2020

The effects of an HIV-1 immunogen (Remune) on viral load, CD4 cell counts and HIV-specific immunity in a double-blind, randomized, adjuvant-controlled subset study in HIV infected subjects regardless of concomitant antiviral drugs

1 reference

12 December 2020

Human immunodeficiency virus isolated from a serum sample collected in 1976 in Central Africa

1 reference

12 December 2020

Effect of gamma irradiation on the human immunodeficiency virus and human coagulation proteins

1 reference

12 December 2020

Effect of immunization with inactivated gp120-depleted human immunodeficiency virus type 1 (HIV-1) immunogen on HIV-1 immunity, viral DNA, and percentage of CD4 cells

1 reference

12 December 2020

Randomised trial of MNrgp120 HIV-1 vaccine in symptomless HIV-1 infection

1 reference

12 December 2020

HIV type 1 isolate Z321, the strain used to make a therapeutic HIV type 1 immunogen, is intersubtype recombinant

1 reference

12 December 2020

Phase II controlled trial of post-exposure immunization with recombinant gp160 versus antiretroviral therapy in asymptomatic HIV-1-infected adults. VaxSyn Protocol Team

1 reference

12 December 2020

Anti-F(ab')2 antibody in HIV type 1 infection: relationship to hypergammaglobulinemia and to antibody specific to the V3 loop region of glycoprotein 120

1 reference

12 December 2020

Highly active antiretroviral therapy during early HIV infection reverses T-cell activation and maturation abnormalities. Swiss HIV Cohort Study.

1 reference

12 December 2020

Immunogenicity of three Haemophilus influenzae type b protein conjugate vaccines in HIV seropositive adults and analysis of predictors of vaccine response.

1 reference

12 December 2020

Recombinant gp160 as a therapeutic vaccine for HIV-infection: results of a large randomized, controlled trial

1 reference

12 December 2020

Investigations of the use of beta-propiolactone in virus inactivation

1 reference

12 December 2020